Holen Sie sich die Stockscreener-App
134.80
0.16%
-0.21
Handel nachbörslich:
134.80
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Teleflex Incorporated Aktie (TFX) Neueste Nachrichten
Teleflex Awarded National Central Venous Access Agreement with Premier, Inc. - Yahoo Finance
Bessemer Group Inc. Grows Stake in Teleflex Incorporated $TFX - MarketBeat
Teleflex stock holds gains as higher margins support outlook - Ad-hoc-news.de
Teleflex stock holds as the company works through its 2026 reset - Ad-hoc-news.de
Heartland Advisors Inc. Has $25.84 Million Stake in Teleflex Incorporated $TFX - MarketBeat
Teleflex stock trades steady as recent earnings highlight margin resilience - Ad-hoc-news.de
Teleflex stock trades steady as investors weigh strong 2024 guidance and margin expansion - ad-hoc-news.de
Teleflex stock holds steady as earnings metrics frame the setup - ad-hoc-news.de
Is Teleflex (TFX) Still Below Fair Value As Its Recovery Story Rebuilds? - Sahm
Teleflex Details ESG Progress in 2025 Global Impact Report - MyChesCo
Teleflex Inc. stock outperforms competitors on strong trading day - MarketWatch
Fifth Third Bancorp Buys 66,082 Shares of Teleflex Incorporated $TFX - MarketBeat
Teleflex (NYSE:TFX) Price Target Raised to $145.00 at Mizuho - MarketBeat
Teleflex Is Maintained at Neutral by Mizuho - Moomoo
Y Intercept Hong Kong Ltd Trims Stake in Teleflex Incorporated $TFX - MarketBeat
Teleflex Inc (TFX) Shares Fall 4.6% -- What GF Score of 76 Tells Investors - GuruFocus
Teleflex Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Teleflex (NYSE:TFX) Trading Down 5.5%Time to Sell? - MarketBeat
What's behind Teleflex's latest 4.9% stock pullback? - Traders Union
TFX4566956 Bond Profile — Key Metrics - TradingView
TFX4991347 Bond Risk Profile - TradingView
Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector - DirectorsTalk Interviews
Teleflex stock reflects steady medical device demand amid global healthcare investment - Ad Hoc News
BMO Capital Markets Upgrades Teleflex (NYSE:TFX) to "Strong-Buy" - MarketBeat
Teleflex (NYSE:TFX) Stock Crosses Above 200-Day Moving AverageHere's Why - MarketBeat
ETFs Investing in Teleflex Incorporated Stocks - TradingView
Intuitive, Globus, Teleflex named top picks as BMO initiates MedTech on buying opportunity - Seeking Alpha
Teleflex stock holds steady on its medical device base - Ad-hoc-news.de
Teleflex Inc : BMO Initiates Coverage With Ou - Moomoo
Teleflex Inc. focuses on medical devices as investors track its Nasdaq listing - ad-hoc-news.de
Teleflex Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Is Teleflex (TFX) Quietly Recasting Its Interventional Cardiology Ambitions Through the BIOMAG Trials? - Sahm
Teleflex Inc. focuses on medical devices and long-term growth - ad-hoc-news.de
Teleflex Publishes 2025 Global Impact Report - Business Wire
Teleflex (TFX) Starts BIOMAG III As Freesolve Progress Tests Its Fair Value Story - Sahm
Teleflex Inc focuses on medical devices as investors watch long term growth - ad-hoc-news.de
Teleflex Arrow EZ-IO System from Teleflex Inc.Vascular access tool that is shaping emergency care - AD HOC NEWS
Teleflex Inc. focuses on medical device growth as investors watch US market exposure - ad-hoc-news.de
Teleflex Incorporated (TFX) Stock Analysis: Exploring an 8.88% Potential Upside Amid Strong Revenue Growth - DirectorsTalk Interviews
CVC Capital and GTCR make joint bid to take Teleflex private - Private Equity Insights
Teleflex Inc. focuses on specialty medical devices amid steady demand - AD HOC NEWS
The Teleflex Arrow EZ-IO System. A rugged emergency access tool built for seconds - AD HOC NEWS
Teleflex Q1 2026 slides: earnings beat amid margin pressure, buyback starts early - Investing.com
Teleflex stock leans on its medical devices base - AD HOC NEWS
TFX News | TELEFLEX INC (NYSE:TFX) - ChartMill
Teleflex Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Teleflex Dodges Bid to Revive Patent Case Over Laryngoscopes - Bloomberg Law News
Teleflex Inc. focuses on medical devices as investors watch long-term growth prospects - AD HOC NEWS
List of 16 Acquisitions by Teleflex Medical (Jul 2026) - Tracxn
Teleflex advances heart scaffold trial, shares trade below recent highs - AD HOC NEWS
Teleflex Inc. stock underperforms Monday when compared to competitors - MarketWatch
Teleflex Incorporated (TFX) Stock Analysis: A Closer Look At Its 12.34% Potential Upside - DirectorsTalk Interviews
Teleflex Incorporated (TFX) Stock Price Today - CoinMarketCap
The UroLift System from Teleflex Inc.minimally invasive relief for BPH patients - AD HOC NEWS
Should Teleflex’s Bioresorbable Scaffold Trial Progress Require Action From Teleflex (TFX) Investors? - simplywall.st
Teleflex focuses on vascular devices, peers show sector momentum - Ad-hoc-news.de
Enterprise value to EBITDA forward of Teleflex Incorporated – NYSE:TFX - TradingView
Enterprise value to EBITDA forward of Teleflex Incorporated – BX:TBH - TradingView
Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Inco - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Investors to Connect - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporat - The National Law Review
Price to sales forward of Teleflex Incorporated – NYSE:TFX - TradingView
Teleflex (TFX) Could Be 43% Undervalued Following BIOMAG III Study Enrollment - Sahm
Price to sales forward of Teleflex Incorporated – BX:TBH - TradingView
Teleflex Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Teleflex Incorporated Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh - TradingView
Enterprise value to EBIT forward of Teleflex Incorporated – NYSE:TFX - TradingView
2.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):